Combined oral upadacitinib and 308-nm excimer light for refractory progressive non-segmental vitiligo: A prospective observational study in 14 adults and 2 pediatric cases
收藏Mendeley Data2026-04-09 收录
下载链接：
https://data.mendeley.com/datasets/dz4cwrc68x/1
下载链接
链接失效反馈官方服务：
资源简介：
VASI scores of 16 patients (adults and children) with progressive refractory non-segmental vitiligo treated with oral upadacitinib combined with 308-nm excimer light at 12, 16, 20, and 24 weeks.
